Prediction of Peritoneal Cancer Index and Prognosis in Peritoneal Metastasis of Gastric Cancer Using NLR-PLR-DDI Score: A Retrospective Study
Zeyao Ye,Pengfei Yu,Yang Cao,Tengjiao Chai,Sha Huang,Xiangdong Cheng,Yian Du
DOI: https://doi.org/10.2147/CMAR.S343467
2022-01-12
Cancer Management and Research
Abstract:Zeyao Ye, &ast Pengfei Yu, &ast Yang Cao, Tengjiao Chai, Sha Huang, Xiangdong Cheng, Yian Du Department of Gastric Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yian Du; Xiangdong Cheng Department of Gastric Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, People's Republic of China Tel +86-571-88128041 Email ; Objective: The peritoneal cancer index (PCI) is used to evaluate the peritoneal metastasis of gastric cancer. A higher value indicates more widespread and/or larger tumors in the peritoneal cavity. The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) are representative blood markers of systemic inflammatory responses, and D-dimer (DDI) is the final stable product of fibrin. This study explores the association of NLR, PLR, and DDI with PCI and assesses the clinical utility of a new blood score combining the NLR, PLR, and DDI (NPD score) for PCI and the prognosis prediction of gastric cancer. Methods: This was a single-center, nonrandomized, retrospective, cohort study. We evaluated the risk factors for high PCI (≥ 15) using univariate and multivariate analyses. According to the findings of the ROC analysis, we determined the cut-off values of NLR, PLR and DDI and created the NPD score. The patients were grouped into high-risk and low-risk groups based on their NPD score (< 2 and ≥ 2, respectively). Results: Univariate and multivariate analysis demonstrated that the NLR, PLR, and DDI were independent risk factors for high PCI (P < 0.05). The NPD score of the high-risk group was ≥ 2, and the NPD score of the low-risk group was < 2. The median survival time was 14.2 in the high-risk group and 25.6 in the low-risk group. The NPD score was significantly higher in the high-PCI group than that in the low-PCI group. The survival of the high-risk group was significantly worse than that of the low-risk group (P = 0.003). NPD score decrease was an independent predictive factor for PCI decrease. Conclusion: NLR, PLR, and DDI are potential independent risk factors for high PCI in patients with peritoneal metastasis of gastric cancer. The NPD scoring system can help in predicting PCI and the prognosis of patients with peritoneal metastasis of gastric cancer. Keywords: gastric cancer, peritoneal metastasis, peritoneal cancer index, PCI, NLR-PLR-DDI score, prognosis Gastric cancer is one of the most common gastrointestinal malignancies and the third leading cause of cancer-related mortality worldwide. 1 Peritoneal metastasis is often responsible for treatment failure in gastric cancer. It has been reported that approximately 60% of gastric cancer patients eventually die from peritoneal dissemination. 2,3 Once peritoneal metastasis begins, refractory ascites, intestinal obstruction, and cachexia may appear, which are the main causes of death in patients with advanced gastric cancer. 4 Peritoneal dissemination has a poor prognosis irrespective of whether the disease is at the initial, progression, or recurrent stage. Noninvasive, sensitive, and specific biomarkers are required to determine peritoneal dissemination. Traditional imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) are not sensitive enough for the detection and evaluation of peritoneal metastasis. Therefore, diagnostic staging laparoscopy (DSL) is performed to confirm the diagnosis and extent of peritoneal metastasis. 5 The peritoneal cancer index (PCI) is a useful tool to assess disease extensity and can help in determining the prognosis and operability of peritoneal metastasis. 6,7 This classification system divides the abdomen into nine sectors and the small bowel into four additional sectors. The lesion size score for each sector is summed up to determine the total score (Figure 1). 7 Figure 1 Peritoneal Cancer Index (PCI) scoring system. 7 Notes: Data from Tabrizian et al. The systemic inflammatory response is closely related to the progression of malignant tumors, including gastric cancer. 8,9 The neutrophil-to-lymphocyte ratio (NLR) and platelet-to lymphocyte ratio (PLR) are important hematological biomarkers and can be used as significant prognostic markers in several neoplasms, including gastric cancer. 10–13 D- -Abstract Truncated-
oncology